SHSE:688298 (China)
Â
Class A
Â¥
17.87
-0.65 (-3.51%)
Jul 24
Business Description
Zhejiang Orient Gene Biotech Co Ltd
ISIN : CNE100003RM8
Share Class Description:
SHSE:688298: Class ATotal Employee Number:
2,283Compare
Compare
Traded in other countries / regions
688298.China Index Membership
SSE Composite Index IPO Date
2020-02-05Description
Zhejiang Orient Gene Biotech Co Ltd is engaged in production, research, development and sale of vitro diagnostic products. The company's products include Genetic diagnosis, Colloidal gold rapid diagnostic tests, Dry chemical strips (urinalysis), Bio-liquid diagnostic kits, Clinical test instruments, POCT time-resolved Fluor immunoassay Test kit (TRFI), and Raw materials.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 7.36 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.6 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.78 | |||||
Beneish M-Score | -2.9 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -54.5 | |||||
3-Year Book Growth Rate | -9.8 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 19.04 | |||||
9-Day RSI | 31.34 | |||||
14-Day RSI | 36.25 | |||||
3-1 Month Momentum % | -13.77 | |||||
6-1 Month Momentum % | -25.28 | |||||
12-1 Month Momentum % | -35.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.79 | |||||
Quick Ratio | 3.42 | |||||
Cash Ratio | 2.99 | |||||
Days Inventory | 198.74 | |||||
Days Sales Outstanding | 72.1 | |||||
Days Payable | 293.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 5.15 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 43.88 | |||||
Operating Margin % | -37.02 | |||||
Net Margin % | -54.56 | |||||
EBITDA Margin % | -53.79 | |||||
FCF Margin % | -45.12 | |||||
OCF Margin % | -16.68 | |||||
ROE % | -8.84 | |||||
ROA % | -7.48 | |||||
ROIC % | -8.81 | |||||
3-Year ROIIC % | -179.37 | |||||
ROC (Joel Greenblatt) % | -19.66 | |||||
ROCE % | -8.3 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 3.23 | |||||
PS Ratio | 3.35 | |||||
PB Ratio | 0.61 | |||||
Price-to-Tangible-Book | 0.72 | |||||
EV-to-EBIT | -2.98 | |||||
EV-to-EBITDA | -2.98 | |||||
EV-to-Revenue | 1.6 | |||||
EV-to-FCF | -3.55 | |||||
Price-to-GF-Value | 0.58 | |||||
Price-to-Projected-FCF | 0.33 | |||||
| Price-to-Net-Current-Asset-Value | 1.77 | |||||
| Price-to-Net-Cash | 2.57 | |||||
Earnings Yield (Greenblatt) % | -33.56 | |||||
FCF Yield % | -12.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang Orient Gene Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,011.693 | ||
| EPS (TTM) (Â¥) | -2.9 | ||
| Beta | 1.1384 | ||
| 3-Year Sharpe Ratio | -0.81 | ||
| 3-Year Sortino Ratio | -0.98 | ||
| Volatility % | 21.4 | ||
| 14-Day RSI | 36.25 | ||
| 14-Day ATR (Â¥) | 0.813181 | ||
| 20-Day SMA (Â¥) | 19.085 | ||
| 12-1 Month Momentum % | -35.84 | ||
| 52-Week Range (Â¥) | 17.03 - 30.6 | ||
| Shares Outstanding (Mil) | 201.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhejiang Orient Gene Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhejiang Orient Gene Biotech Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| 1.2:1 Stock Split | 2023-06-26 | 40.03 (-2.52%) | ||
| 1.4:1 Stock Split | 2022-06-16 | 112.10 (-0.95%) |
Show
Entries
Zhejiang Orient Gene Biotech Co Ltd Frequently Asked Questions
What is Zhejiang Orient Gene Biotech Co Ltd(SHSE:688298)'s stock price today?
The current price of SHSE:688298 is ¥17.87. The 52 week high of SHSE:688298 is ¥30.60 and 52 week low is ¥17.03.
When is next earnings date of Zhejiang Orient Gene Biotech Co Ltd(SHSE:688298)?
The next earnings date of Zhejiang Orient Gene Biotech Co Ltd(SHSE:688298) is .
Does Zhejiang Orient Gene Biotech Co Ltd(SHSE:688298) pay dividends? If so, how much?
Zhejiang Orient Gene Biotech Co Ltd(SHSE:688298) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Zhejiang Orient Gene Biotech Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers